1. Home
  2. SINT vs SNSE Comparison

SINT vs SNSE Comparison

Compare SINT & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$3.62

Market Cap

14.6M

Sector

Health Care

ML Signal

HOLD

Logo Sensei Biotherapeutics Inc.

SNSE

Sensei Biotherapeutics Inc.

HOLD

Current Price

$10.02

Market Cap

13.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
SNSE
Founded
1996
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6M
13.9M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
SINT
SNSE
Price
$3.62
$10.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$16.00
$72.50
AVG Volume (30 Days)
41.4K
73.3K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,270,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$80.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.71
$5.00
52 Week High
$7.36
$18.35

Technical Indicators

Market Signals
Indicator
SINT
SNSE
Relative Strength Index (RSI) 46.67 51.29
Support Level $3.65 $11.14
Resistance Level $3.94 $12.00
Average True Range (ATR) 0.22 1.12
MACD -0.01 0.00
Stochastic Oscillator 9.58 55.92

Price Performance

Historical Comparison
SINT
SNSE

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

Share on Social Networks: